Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
15462 | 641 | 25.3 | 57% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CROSSED ALDOL CONDENSATION | Author keyword | 26 | 80% | 2% | 16 |
2 | CYCLIC CHALCONE ANALOGUES | Author keyword | 18 | 89% | 1% | 8 |
3 | CROSS ALDOL CONDENSATION | Author keyword | 17 | 68% | 2% | 15 |
4 | 4 PIPERIDONES | Author keyword | 13 | 67% | 2% | 12 |
5 | MURINE TOXICITY | Author keyword | 11 | 100% | 1% | 6 |
6 | PHARM NUTR | Address | 10 | 12% | 13% | 81 |
7 | ALPHA ALPHA BISSUBSTITUTED BENZYLIDENECYCLOALKANONES | Author keyword | 9 | 83% | 1% | 5 |
8 | DRUG DESIGN DISCOVERY GRP | Address | 8 | 41% | 2% | 16 |
9 | 2 6 BISBENZYLIDENECYCLOHEXANONE | Author keyword | 4 | 75% | 0% | 3 |
10 | 3 5 BISARYLIDENE 4 PIPERIDONES | Author keyword | 4 | 75% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ALPHA ALPHA BISSUBSTITUTED BENZYLIDENECYCLOALKANONES | 47 | 88% | 3% | 22 |
2 | 2 ARYLIDENEBENZOCYCLOALKANONES | 38 | 78% | 4% | 25 |
3 | CONJUGATED STYRYL KETONES | 35 | 86% | 3% | 18 |
4 | BENZYLIDENECYCLOALKANONES | 26 | 100% | 2% | 11 |
5 | ALPHA ALPHA BISSUBSTITUTED BENZYLIDENE CYCLOALKANONES | 23 | 100% | 2% | 10 |
6 | CROSS ALDOL CONDENSATION | 23 | 74% | 3% | 17 |
7 | STYRYL KETONES | 21 | 78% | 2% | 14 |
8 | BENZYLIDENE CYCLOALKANONES | 17 | 100% | 1% | 8 |
9 | CYCLOALKANONES | 14 | 37% | 5% | 31 |
10 | CORRESPONDING AZINE DERIVATIVES | 14 | 100% | 1% | 7 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
1,5-Diaryl-3-oxo-1,4-pentadienes: A Case for Antineoplastics with Multiple Targets | 2009 | 30 | 81 | 40% |
Mannich bases in medicinal chemistry and drug design | 2015 | 5 | 470 | 10% |
Cytotoxic Thiol Alkylators | 2007 | 42 | 61 | 15% |
Anticancer and cytotoxic properties of Mannich bases | 1997 | 74 | 57 | 35% |
THE CHEMISTRY OF CROSS-COUPLED DIENONES | 2008 | 2 | 107 | 47% |
Synthesis of exocyclic alpha,beta-unsaturated ketones | 2004 | 19 | 82 | 21% |
COMPUTER-ASSISTED STRUCTURE-ACTIVITY CORRELATIONS | 1984 | 3 | 5 | 40% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PHARM NUTR | 10 | 12% | 13% | 81 |
2 | DRUG DESIGN DISCOVERY GRP | 8 | 41% | 2.5% | 16 |
3 | GOURISHANKAR EDUC SOC | 3 | 100% | 0.5% | 3 |
4 | DRUG DISCOVERY DEV GRP | 1 | 25% | 0.8% | 5 |
5 | BIOINFORMAT INFRASTRUCT IL | 1 | 10% | 1.1% | 7 |
6 | CANC AGING METAB | 1 | 50% | 0.2% | 1 |
7 | CATALYSE CHIMIOMETRIE ENVIRONM URAC 24 | 1 | 50% | 0.2% | 1 |
8 | CHIM MOL GENIE PROC CHIM ENERGET CMGPCE | 1 | 50% | 0.2% | 1 |
9 | CONTAMINANT CONTROLLING BIOL HEBEI PROV | 1 | 50% | 0.2% | 1 |
10 | EA 7341 | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000126009 | CHALCONES//CHALCONE//CLAISEN SCHMIDT CONDENSATION |
2 | 0.0000112115 | IMAGE SCI INFORMAT ENGN//PIPERIDIN 4 ONE//PIPERIDIN 4 ONES |
3 | 0.0000098478 | 1 5 DIOXASPIRO55UNDECANE 2 4 DIONE//STAR COMPOUND//P PHENYLENEDIALDEHYDE |
4 | 0.0000095937 | 1 3 DIAZA 1 3 BUTADIENE//TOSYLATION//BISTRIPHENYLPHOSPHINEPALLADIUMII DICHLORIDE |
5 | 0.0000069795 | 1 AZABICYCLO330OCTANE//SK 946//PERHYDROPYRROLIZINE |
6 | 0.0000061428 | ACRYLONITRILE DERIVATIVES//POLIMEROS QUIM//QUIM TEOR INVEST |
7 | 0.0000059006 | 23H BENZOXAZOLONE//23H BENZOTHIAZOLONE//UNITE CHIM PHARMACEUT |
8 | 0.0000053434 | PYRAZOLINE//PYRAZOLINES//2 PYRAZOLINE |
9 | 0.0000052494 | KNOEVENAGEL CONDENSATION//KNOEVENAGEL REACTION//KNOEVENAGEL |
10 | 0.0000050634 | REX EXCLUSION//BACTERIOPHAGE LAMBDA LAMBDA//CI REXA REXB OPERON |